Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Background: Autism is a pervasive neurodevelopmental disorder. At present there are no defined mechanisms of pathogenesis and therapy is mostly limited to behavioral interventions. Stem cell transplantation may offer a unique treatment strategy for autism due to immune and neural dysregulation observed in this disease. This non-randomized, open-label, single center phase I/II trial investigated the safety and efficacy of combined transplantation of human cord blood mononuclear cells (CBMNCs) and umbilical cord-derived mesenchymal stem cells (UCMSCs) in treating children with autism. Methods: 37 subjects diagnosed with autism were enrolled into this study and divided into three groups: CBMNC group (14 subjects, received CBMNC transplantation and rehabilitation therapy), Combination group (9 subjects, received both CBMNC and UCMSC transplantation and rehabilitation therapy), and Control group (14 subjects, received only rehabilitation therapy). Transplantations included four stem cell infusions through intravenous and intrathecal injections once a week. Treatment safety was evaluated with laboratory examinations and clinical assessment of adverse effects. The Childhood Autism Rating Scale (CARS), Clinical Global Impression (CGI) scale and Aberrant Behavior Checklist (ABC) were adopted to assess the therapeutic efficacy at baseline (pre-treatment) and following treatment. Results: There were no significant safety issues related to the treatment and no observed severe adverse effects. Statistically significant differences were shown on CARS, ABC scores and CGI evaluation in the two treatment groups compared to the control at 24 weeks post-treatment (p < 0.05). Conclusions: Transplantation of CBMNCs demonstrated efficacy compared to the control group; however, the combination of CBMNCs and UCMSCs showed larger therapeutic effects than the CBMNC transplantation alone. There were no safety issues noted during infusion and the whole monitoring period. Trial registration: ClinicalTrials.gov: NCT01343511, Title “Safety and Efficacy of Stem Cell Therapy in Patients with Autism”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a recent study failed to find any benefit of wild-type microglia in three rodent models of Rett syndrome including the model used in the original study235.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [235]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
(1976) · Medical Entomology and Zoology · Cited by 8,899
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · cited 1×
“It has been proved that the endothelial progenitor cell, contained in a CD34 cell population enriched in CBMNCs, has the capacity to trigger angiogenesis in the ischemic tissues [42].”
BackgroundDiagnostic and Statistical Manual of Mental Disorders, 5th Edition
(2013) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890425596.893619 · Cited by 4,383
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 2×
“Studies demonstrated an ongoing neuroinflammatory process with marked activation of microglia and astroglia in the cerebral cortex, white matter and cerebellum of individuals with autism [22].”
BackgroundRisperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
(1985) · PubMed · Cited by 1,427
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940 · cited 1×
“A unique proinflammatory cytokine profile in autistic patients has been documented in the cerebrospinal fluid, including a marked increase in macrophage chemoattractant protein-1 [22], and in the peripheral plasma, such as significantly elevated levels of interleukin (IL)-1β, IL-8 and IL-12p40 [23].”
BackgroundSelf-citationLu, L., Liu, Y.-J., Yang, S.-G., Zhao, Q., Wang, X., Gong, W., Han, Z., Xu, Z., Lu, Y., Liu, D., et al. (2006) · PubMed · Cited by 853
Cited by
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders
Hughes, H. K., Mills Ko, E., Rose, D., & Ashwood, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00405 · Cited by 245
Self-citationConcise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
Davies, J. E., Walker, J. T., & Keating, A. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0492 · Cited by 215
Fibroblasts and mesenchymal stem cells: Two sides of the same coin?
Soundararajan, M., & Kannan, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26860 · Cited by 190
“, 2005), and psychiatric disorders, such as autism (Bradstreet et al., 2014; Dawson et al., 2017; Lv et al., 2013).”
BackgroundUmbilical cord mesenchymal stromal cell transplantations: A systemic analysis of clinical trials
Can, A., Çelikkan, F. T., & Çınar, Ö. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.08.004 · Cited by 145
“[30] transplanted 1 × 10(6)/kg UC-MSCs together with 2 × 10(6)/kg cord blood (CB) MNCs, and 2 × 10(6)/kg of CB-MNCs to patients with autism (n = 14 and n = 9, respectively) via IV and intrathecal routes.”
Method
Metadata
- Authors
- Lv, Y.-T., Zhang, Y., Liu, M., Qiuwaxi, J.-N.-T., Ashwood, P., Cho, S. C., Huan, Y., Ge, R.-C., Chen, X.-W., Wang, Z.-J., Kim, B.-J., & Hu, X.
- Affiliations
- Beike Biotechnology (China) (CN)
- Shandong Jiaotong Hospital (CN)
- University of California, Davis (US)
- Korea University (KR)
- Corresponding author
- Hu, Xiang
- Venue
- Journal of Translational Medicine
- Published
- 2013-08-27
- Volume
- 11
- Issue
- 1
- Pages
- 196-196
- ISSN
- 1479-5876 (ISSN-L)
- PMC
- PMC3765833
- OpenAlex
- W2149113453
- Cited by
- 174
- References
- 53
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 14 · 2023: 13 · 2022: 14 · 2021: 16 · 2020: 23 · 2019: 13 · 2018: 11 · 2017: 13 · 2016: 13 · 2015: 15 · 2014: 12
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Translational Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, stem cell transplantation, cord blood mononuclear cells, human umbilical cord mesenchymal stem cells, intrathecal administration, treatment safety, treatment efficacy, children, rehabilitation therapy, aberrant behavior, neurodevelopmental disorders
- MeSH terms
- Autistic Disorder, Child, Child, Preschool, Female, Humans, Leukocytes, Mononuclear, Male, Umbilical Cord, Treatment Outcome, Cord Blood Stem Cell Transplantation, Mesenchymal Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. https://app.cochat.ai/papers/10.1186/1479-5876-11-196
- The paper
- Lv, Y.-T., Zhang, Y., Liu, M., Qiuwaxi, J.-N.-T., Ashwood, P., Cho, S. C., Huan, Y., Ge, R.-C., Chen, X.-W., Wang, Z.-J., Kim, B.-J., & Hu, X. (2013). Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-11-196
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
